• Home
• PhD Program
• 3.1.26 Phthisiology

3.1.26 Phthisiology

1. General issues in phthisiology 2. Biosafety. Biological diversity of properties of microorganisms causing mycobacteriosis, tuberculosis and socially significant infectious diseases. 3. Differentiation and pathologic regulation of immunity in tuberculosis and co-infectious diseases. 4. Means and methods of diagnostics of socially significant infections, predictors of their unfavorable course. 5. Extrapulmonary forms of tuberculosis: diagnosis, detection, management tactics, prophylaxis, treatment. 6. Personalization of treatment of patients with tuberculosis and/or combined with it diseases. 7. Pharmacological substances and dosage forms for treatment and prevention of socially significant diseases. New biomaterials and nanotechnologies in the treatment of socially significant diseases. 8. Negative effects of polychemotherapy: diagnosis, predictors of development, correction. 9. Organization and improvement of anti-epidemic measures. 10. Prevention of spread of tuberculosis infection individual and population (specific and nonspecific). 11. Organizational and epidemiological studies. 12. Rehabilitation of persons with socially significant infections. 13. Information technologies in phthisiatry. 14. Radiation diagnostics and differential diagnostics of tuberculosis and diseases combined with it. 15. Study of the prevalence and peculiarities of the course of socially significant diseases, improvement of technologies of their prevention and treatment in the indigenous and native population in the Far North and equated areas.